David Wasserstein

David Wasserstein

Auto-generated profile, based on publicly available information

David Wasserstein

Schatzker Joint Preservation Initiative – Division of Orthopedic Surgery, Sunnybrook Health Sciences Centre University of Toronto Toronto Ontario Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
BRBheeshma Ravi
Bheeshma Ravi
DPDaniel Pincus
Daniel Pincus
HKHayat Khan
Hayat Khan
DWDavid Wasserstein
David Wasserstein
RJRichard Jenkinson
Richard Jenkinson
HKHans J. Kreder
Hans J. Kreder
Background: Although the prevalence of displaced femoral neck fractures in the elderly population is increasing worldwide, there remains controversy as to whether these injuries should be managed with hemiarthroplasty or total hip arthroplasty. Although total hip arthroplasties result in better function, they are more expensive and may have higher complication rates. Our objective was to compare the complication rates and health-care costs between hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures in the elderly population. Methods: A population-based, retrospective cohort study was performed on adults (≥60 years of age) undergoing either hemiarthroplasty or total hip arthroplasty for hip fracture between April 1, 2004, and March 31, 2014. We excluded patients who resided in long-term care facilities prior to the injury and those who were discharged to these facilities after the surgical procedure. Patients who underwent a hemiarthroplasty and those who underwent a total hip arthroplasty were matched using a propensity score encompassing patient demographic characteristics, patient comorbidities, and provider factors. After matching, we compared the rates of medical and surgical complications, as well as the perioperative and postoperative health-care costs in the year following the surgical procedure. The primary outcome was the occurrence of a medical complication (acute myocardial infarction, deep venous thrombosis, pulmonary embolism, ileus, pneumonia, renal failure) within 90 days or a surgical complication (dislocation, infection, revision surgical procedure) within 1 year. Additionally, we examined the change in health-care costs in the year following the surgical procedure, including costs associated with the index admission, relative to the year before the surgical procedure. Results: Among 29,121 eligible patients, 2,713 (9.3%) underwent a total hip arthroplasty. After successfully matching 2,689 patients who underwent a total hip arthroplasty with those who underwent a hemiarthroplasty, the patients who underwent a total hip arthroplasty were at an increased risk for dislocation (1.7% compared with 1.0%; p = 0.02), but were at a decreased risk for revision (0.2% compared with 1.8%; p < 0.0001), relative to patients who underwent a hemiarthroplasty. Furthermore, the overall increase in the annual health-care expenditure in the year following the surgical procedure was approximately $2,700 in Canadian dollars lower in patients who underwent a total hip arthroplasty (p < 0.001). Conclusions: Among elderly patients with displaced femoral neck fractures, total hip arthroplasty was associated with lower rates of revision surgical procedures and reduced health-care costs during the index admission and in the year following the surgical procedure, relative to hemiarthroplasty. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

15 August 2018 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
DPDaniel Pincus
Daniel Pincus
DWDavid Wasserstein
David Wasserstein
BRBheeshma Ravi
Bheeshma Ravi
AHAnjie Huang
Anjie Huang
JPJ. Michael Paterson
J. Michael Paterson
WWWalter Wodchis
Walter Wodchis
Background: Waiting for hip fracture surgery is associated with complications. The objective of this study was to determine whether waiting for hip fracture surgery is associated with health-care costs. Methods: We conducted a population-based, propensity-matched cohort study of patients treated between 2009 and 2014 in Ontario, Canada. The primary exposure was early hip fracture surgery, performed within 24 hours after arrival at the emergency department. The primary outcome was direct medical costs, estimated for each patient in 2013 Canadian dollars, from the payer perspective. The costs in the early and delayed groups were then compared using a difference-in-differences approach: the baseline cost in the year prior to the hip fracture that had been accrued by patients with early surgery was subtracted from the cost in the first year following the surgery (first difference), and the difference was then compared with the same difference among propensity-score-matched patients who had received delayed surgery (second difference). The secondary outcome was the postoperative length of stay (in days). Results: The study included 42,230 patients who received hip fracture surgery from a total of 522 different surgeons at 72 hospitals. The mean cost (and standard deviation) attributed to the hip fracture was $39,497 ± $46,645 per person. The matched patients who underwent surgery after 24 hours had direct 1-year medical costs that were an average of $2,638 higher (95% confidence interval [CI] = $1,595 to $3,680, p < 0.0001) and a postoperative length of stay that was an average of 0.610 day longer (95% CI = 0.1749 to 1.0331 days, p = 0.0058) compared with those who underwent surgery within 24 hours. Conclusions: Waiting >24 hours for hip fracture surgery was associated with increased medical costs and length of stay. Costs incurred by waiting may provide a financial incentive to mitigate delays in hip fracture surgery. Level of Evidence: Economic Level III. Please see Instructions for Authors for a complete description of levels of evidence.

29 September 2025 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
THTyler M. Hauer
Tyler M. Hauer
RVRomed Peter Vieider
Romed Peter Vieider
DWDavid Wasserstein
David Wasserstein
MOMatthieu Ollivier
Matthieu Ollivier
VMVolker Musahl
Volker Musahl
Purpose: While traditional high tibial osteotomy (HTO) techniques primarily address malalignment in the coronal plane, the significance of sagittal plane alignment, particularly the posterior tibial slope (PTS), is not to be overlooked in the setting of cruciate ligament insufficiency. Combined deformities involving both the coronal plane and the sagittal plane are less common and present unique surgical challenges. This narrative review summarizes the literature and introduces tips and tricks for managing complex biplanar deformities through a case‐based discussion of different techniques. Methods: This narrative review includes preoperative planning, surgical techniques, clinical outcomes and illustrative clinical cases detailing surgical rationale and technical nuances in the correction of biplanar proximal tibial deformities. Emphasis is placed on the importance of accurate assessment and correction of biplanar deformities to optimize patient outcomes. Four representative technique presentations are included: (1) Hybrid HTO with a posterior opening wedge (POW) and anterior closing wedge (ACW), (2) asymmetrical medial closing wedge (MCW) HTO, (3) medial opening wedge (MOW) HTO with an anterolateral hinge and (4) a double HTO with both an infratuberosity ACW and high MOW. Conclusion: Biplanar HTO is a knee‐preserving surgical option for a small cohort of patients with complex knee deformities involving both the coronal and sagittal planes. Precise preoperative planning and meticulous surgical execution are essential to address these biplanar malalignments effectively. This narrative review serves as a guide for orthopaedic surgeons, highlighting key considerations when planning biplanar HTO and serves as a practical guide for complex cases. Level of Evidence: Level V.

1 January 2025 in JBJS Case Connector
Verified
Journal Article
Closed access
BBBenjamin Blackman
Benjamin Blackman
MSManpreet Singh Sidhu
Manpreet Singh Sidhu
ASAjay Shah
Ajay Shah
JMJennah Mann
Jennah Mann
PMPaul Marks
Paul Marks
DWDavid Wasserstein
David Wasserstein
Case: A 13-year-old adolescent boy presented with chronic anterior cruciate ligament (ACL) insufficiency and prior medial meniscectomy. Radiographic evaluation revealed a posterior tibial slope (PTS) of 20°, putting him at high risk of reinjury following ACL reconstruction (ACLR). Guided growth using anteriorly placed eight plates was used for 9 months, which reduced his PTS to 6°. Two months following plate removal, the patient underwent ACLR with lateral extra-articular tenodesis. Conclusion: This previously proposed but never reported approach suggests that guided growth is a viable option to correct excessive PTS before ACLR in skeletally immature patients.

1 January 2026 in JBJS Reviews
Verified
Journal Article
Closed access
ASAjay Shah
Ajay Shah
NPNikhil Aman Patel
Nikhil Aman Patel
RURishab Udiaver
Rishab Udiaver
BRBheeshma Ravi
Bheeshma Ravi
CWCari Whyne
Cari Whyne
DWDavid Wasserstein
David Wasserstein
Background: Administering recombinant human growth hormone (rHGH) in a medically directed fashion has emerged as an investigational therapeutic intervention in clinical research to improve orthopaedic and sports medicine-related outcomes. Literature suggests that rHGH administration may improve athletic performance and influence osteoporosis and hip fracture outcomes. The purpose of this systematic review is to examine dosage regimens, identify adverse events, and summarize published peer-reviewed data of clinical outcomes where rHGH has been used in orthopaedic surgery human clinical studies to identify potential patient population targets, gaps in knowledge, and risks of use. Methods: Three databases (Embase, PubMed, and MEDLINE) were searched using search terms including but not limited to “human growth hormone,” “muscle strength,” and “bone healing.” Duplicate studies were removed and were subsequently screened first by title and abstract, followed by full-text. The reference lists of included studies were also evaluated with title screen. Data were abstracted and underwent pooled analysis, including meta-analysis where possible. Results: The initial search produced 2,047 unique studies. A total of 22 studies with moderate methodological quality were included, which comprised 1,157 total patients, with a mean age of 54.3 years and a mean daily rHGH dose of 1.49 mg/d. Administration of rHGH led to a dose-dependent increase in serum insulin-like growth factor 1 (mean increase +133.2%). Lean body mass increased in 15 of the 23 studies (mean difference of +3.63% vs. placebo). Leg extension strength increased for rHGH administration vs. placebo (mean difference +3.17%). The most common adverse events in GH patients were peripheral edema (odds ratio [OR] = 3.03), carpal tunnel symptoms (OR = 3.85), and arthralgias (OR = 2.94). Conclusion: rHGH administration led to improvements in clinical outcomes; however, the noteworthy side effects should also be taken into consideration when designing a treatment regimen for orthopaedic-related pathologies. Level of Evidence: Therapeutic Level II , systematic review of Level I and II studies. See Instructions for Authors for a complete description of levels of evidence.